| Name | 4-methyl-2,3-dihydro-1,4-benzoxazine-6-sulfonyl chloride |
|---|---|
| Synonyms |
4-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-sulfonylchloride
3,4-dihydro-4-methyl-2H-1,4-benzoxazin-6-ylsulfonyl chloride 3,4-dihydro-4-methyl-2H-1,4-benzoxazine-6-sulfonyl chloride 4-methyl-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonyl chloride 4-methyl-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonyl chloride 4-methyl-3,4-dihydro-2H-benzo[b][l,4]oxazine-6-sulfonyl chloride |
| Density | 1.415 g/cm3 |
|---|---|
| Boiling Point | 387.7ºC at 760 mmHg |
| Molecular Formula | C9H10ClNO3S |
| Molecular Weight | 247.69900 |
| Flash Point | 188.3ºC |
| Exact Mass | 247.00700 |
| PSA | 54.99000 |
| LogP | 2.58850 |
| HS Code | 2934999090 |
|---|
|
~27%
892948-94-6 |
| Literature: MEMORY PHARMACEUTICALS CORPORATION Patent: US2008/200471 A1, 2008 ; Location in patent: Page/Page column 47 ; US 20080200471 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |